SHARE

FEATURED STORY February 23, 2023

How Employers Should Prepare for the End of the COVID-19 National and Public Health Emergencies

You've Reached Your
Free Article Limit This Month
Register for free to get unlimited access to all Law.com OnPractice content.
Register Now

On January 30, 2023, the Biden administration announced its intention to make final extensions of both the COVID-19 National Emergency (NE) and the COVID-19 Public Health Emergency (PHE) through May 11, 2023, at which point both will end. These emergency declarations have been in place for nearly three years and have enabled the government to modify certain coverage requirements by Medicare, Medicaid and private insurance plans, as well as benefits administration rules. The end of the PHE and NE may mean added costs for benefits plans and new questions regarding compliance.

The differences between and impact of the PHE and NE are commonly misunderstood. While both are declared by different individuals, both are ultimately controlled by the current administration. The PHE and NE have different impacts on plan administration and benefit plan requirements.

This series will explore the implications of the PHE and NE and what their impending end may mean for benefit plan sponsors. These articles will be released periodically before May 11.

IN DEPTH


PHE VERSUS NE

The Secretary of the US Department of Health and Human Services (HHS) first declared a public health emergency in January 2020 for the COVID-19 pandemic. This PHE has been routinely renewed in 90-day increments.

Former President Trump first issued a national emergency declaration in March 2020. A national emergency declaration is in effect until it is terminated by the president or through a joint resolution by Congress.

In response to these federal emergency declarations, the Internal Revenue Service (IRS) and other government agencies have issued various forms of regulatory and other relief. Further, Congress has enacted legislative relief, including certain provisions in the Coronavirus Aid, Relief, and Economic Security (CARES) Act and the Consolidated Appropriations Acts (CAA). Much of this relief is tied to the end of both the NE and the PHE.

EMPLOYEE BENEFITS IMPACTED BY THE PHE AND NE

There are several important benefit coverage and administration requirements connected to the PHE and/or NE that may remain the same, remain for a temporary period or may need to be discontinued upon the end of these federal emergencies. Over the course of the upcoming weeks, we will cover the key topics that may be triggered by the end of the PHE and/or NE, including:

  • COVID-19 Testing (Part 2 of 10)
  • COVID-19 Vaccines (Part 3 of 10)
  • Telehealth (Part 4 of 10)
  • Mental Health Parity (Part 5 of 10)
  • High Deductible Health Plans, Health Savings Accounts and Employee Assistance Plans (Part 6 of 10)
  • Deadline Tolling Applied to Each of:
    • COBRA (Part 7 of 10)
    • Claims and Appeals + External Review (Part 8 of 10)
    • HIPAA Special Enrollment (Part 9 of 10)
    • Other Plan-Related Notices (Part 10 of 10)

Note that the items covered above are not an exhaustive list of all legislative and regulatory changes that could affect employee benefit plans. This series is meant to keep employers informed about some of the most important upcoming changes and the impending decisions and disclosures that need to be made.

For any questions regarding the end of the PHE and/or NE, please contact your regular McDermott lawyer or one of the authors.

ALM expressly disclaims any express or implied warranty regarding the OnPractice Content, including any implied warranty that the OnPractice Content is accurate, has been corrected or is otherwise free from errors.

More From McDermott Will & Emery

Welcome Chris Salmen

By Christopher Salmen McDermott Will & Emery May 24 , 2023

Chris Salmen joined McDermott+Consulting earlier this month as a senior director, bringing his unique blend of medical device, diagnostic and digital health experience to advise clients on their go-to-market strategy.

Debt Limit Deadlock Continues

By Debra Curtis McDermott Will & Emery May 22 , 2023

Debbie Curtis and Rodney Whitlock discuss what the debt limit deadlock means for healthcare stakeholders as the June 1 deadline draws closer.

McDermottPlus Check-Up: May 19, 2023

By Debra Curtis McDermott Will & Emery May 19 , 2023

The House and Senate were both in session this week, with significant healthcare activity at the committee level.

More From COVID-19

GT's The Performance Review Episode 20: All Secrets Revealed: Employee Investigations

By Philip I. Person Greenberg Traurig May 24 , 2023

In this episode, Sue Ann Van Dermyden, co-founder and senior partner at one of the nation’s top investigations firms, joins Philip Person and Ryan Bykerk to discuss the ins and outs of employee investigations.

NYC Passes Bill to Update Human Rights Law to Include Discrimination Based on Height, Weight

By Jerrold F. Goldberg Greenberg Traurig May 24 , 2023

On May 11, 2023, the New York City Council passed Intro 209-A, which would amend the New York City Human Rights Law to include prohibitions on discrimination based on height and weight.

Welcome Chris Salmen

By Christopher Salmen McDermott Will & Emery May 24 , 2023

Chris Salmen joined McDermott+Consulting earlier this month as a senior director, bringing his unique blend of medical device, diagnostic and digital health experience to advise clients on their go-to-market strategy.

Featured Stories
Closeclose
Search
Menu

Working...